Profil

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Personál20192020202120222023
Koncoročný počet zamestnancov3 0003 4003 9004 8005 400
Staff turnover in EUR1 281 0741 699 3661 814 3321 695 8751 695 405
Turnover LabelEUREUREUREUREUR
Akcie denominované v EUR20192020202120222023
Akcie v obehu (v miliónoch)2,592,602,50258,052,60
Dividenda na akciu-----
Zisk z podielu bez emisie nových akcií4,5110,299,0112,8213,89
Prehľad ziskov a strát v miliónoch EUR podľa IAS/IFRS20192020202120222023
Obrat4 130,36 209,47 604,48 748,29 839,0
Prevádzkový zisk (EBIT)1 293,22 933,62 593,33 854,73 544,5
Zisk pred zdanením (EBT)1 394,93 116,82 730,44 232,44 379,8
Annual net profit/ loss1 176,82 711,62 342,13 322,03 619,6
Súvaha v miliónoch EUR IAS/IFRS20192020202120222023
Aktíva
Bežné aktíva celkom4 822,88 133,49 560,613 234,814 144,2
Celkové fixné aktíva3 495,63 618,43 871,94 916,18 942,1
Celkové aktíva8 318,511 751,813 432,518 150,923 086,3
Záväzky
Celkové krátkodobé záväzky1 334,81 877,52 142,02 742,13 547,4
Celkové dlhodobé záväzky898,41 187,51 190,51 496,11 958,5
Oprávky celkom0,00,00,00,00,0
Základný kapitál6 085,28 686,810 100,013 912,717 580,4
Celkové záväzky8 318,511 751,813 432,518 150,923 086,3
Management:
Jeffrey Leiden
Alan Garber
Sangeeta Bhatia
Bruce Sachs
Diana McKenzie
Lloyd Carney
Michel Lagarde
Nancy Thornberry
Suketu Upadhyay
Terrence Kearney
Reshma Kewalramani
David Altshuler
Amit K. Sachdev
Bastiano Sanna
Carmen Bozic
Charles F. Wagner
E. Morrey Atkinson
Jonathan Biller
Nia Tatsis
Stuart A. Arbuckle
Predstavenstvo:
Štruktúra akcionárov v %:
AllianceBernstein LP 2,73
Capital Research & Management Co. (Global Investors) 1,38
Capital Research & Management Co. (World Investors) 10,03
Fidelity Management & Research Co. LLC 4,64
Geode Capital Management LLC 2,20
Jennison Associates LLC 1,85
Massachusetts Financial Services Co. 1,40
SSgA Funds Management, Inc. 4,68
T. Rowe Price Associates, Inc. (Investment Management) 2,14
Wellington Management Co. LLP 2,02
Streubesitz 66,93
Adresa: 50 Northern Avenue, 02210 Boston
T: +1-617-341-6100
F: +
I: http://www.vrtx.com
E: mediainfo@vrtx.com